XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.3
GOODWILL AND OTHER INTANGIBLE ASSETS, NET
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS, NET GOODWILL AND OTHER INTANGIBLE ASSETS, NET
Goodwill
The following is a reconciliation of goodwill by segment.
(in millions)Medical Products and TherapiesHealthcare Systems and TechnologiesPharmaceuticalsTotal
Balance as of December 31, 2023$1,241 $3,989 $563 $5,793 
Currency translation (7)— (3)(10)
Balance as of September 30, 2024$1,234 $3,989 $560 $5,783 
Other intangible assets, net
The following is a summary of our other intangible assets.
Indefinite-lived intangible assets
(in millions)Customer relationshipsDeveloped technology, including patentsTrade namesOther amortized intangible assetsTrade namesIn process Research and Development
Total
September 30, 2024
Gross other intangible assets$3,390 $3,182 $963 $87 $680 $157 $8,459 
Accumulated amortization(824)(2,027)(92)(67)— — (3,010)
Other intangible assets, net$2,566 $1,155 $871 $20 $680 $157 $5,449 
December 31, 2023
Gross other intangible assets$3,390 $3,181 $964 $86 $680 $157 $8,458 
Accumulated amortization(654)(1,782)(38)(66)— — (2,540)
Other intangible assets, net$2,736 1,399 926 20 680 157 5,918 
Intangible asset amortization expense was $159 million and $147 million for the three months ended September 30, 2024 and 2023, respectively, and $471 million and $434 million for the nine months ended September 30, 2024 and 2023, respectively.